Reassuringly, our results suggest that TAM treatment of breast cancer patients is unlikely to induce the expression of possibly deleterious complex gangliosides via ST8SIA1 induction in ER-positive breast cancer tumors. The gene discussed is ST8SIA1; the disease is breast cancer.